title: [Use of silicone oil in vitreal hemorrhage complicating proliferated diabetic retinopathy].
abstract: BACKGROUND
  Vitreous hemorrhage is a frequent complication of proliferated diabetic retinopathy. Vitrectomy has vastly improved its prognosis. The purpose of this study was to evaluate the use of silicone oil in vitreal surgery in this indication.
  
  
  METHODS
  We present a retrospective study of 15 eyes that underwent vitrectomy and silicone oil injection for vitreal hemorrhage complicating proliferative diabetic retinopathy. For each patient, we noted the clinical and echographic features, the surgical procedure, and the postoperative outcome after a mean period of 20 months.
  
  
  RESULTS
  The indications for silicone injection were recurrent vitreal hemorrhage (seven eyes), aggressive fibrovascular proliferations (five eyes), and iatrogenic retinal breaks (three eyes). Anatomic success was noted in ten cases. Four patients had a hemorrhage reoccurrence after silicone oil removal and one patient developed neovascular glaucoma. Silicone cataract (seven eyes) and emulsification of silicone (one eye) were noted.
  
  
  CONCLUSIONS
  The use of silicone oil in vitreal surgery for complicated proliferated diabetic retinopathy contributes a hemostatic and plugging effect, but it still has a number of disadvantages such as the need to remove it and its own side effects. It can be beneficial in cases of rubeosis or recurrent hemorrhage. However, it is essentially indicated in recurrent hemorrhage in monophthalmos patients.
authors.affiliation: Service d'ophtalmologie, CHU Habib Bourguiba, Sfax, Tunisie. kharratwassim@yahoo.fr
authors.forename: W
authors.initials: W
authors.lastname: Kharrat
authors.forename: K
authors.initials: K
authors.lastname: Turki
authors.forename: H
authors.initials: H
authors.lastname: Ben Amor
authors.forename: D
authors.initials: D
authors.lastname: Sellami
authors.forename: A
authors.initials: A
authors.lastname: Sellami
authors.forename: A
authors.initials: A
authors.lastname: Trigui
authors.forename: B
authors.initials: B
authors.lastname: Kamoun
authors.forename: Z
authors.initials: Z
authors.lastname: Ben Zina
authors.forename: J
authors.initials: J
authors.lastname: Feki
mesh_terms: D000328:Adult; D003930:Diabetic Retinopathy / Q000150:complications*; D005260:Female; D006489:Hemostatic Techniques; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012827:Silicone Oils / Q000008:administration & dosage*; D014823:Vitreous Hemorrhage / Q000209:etiology* / Q000628:therapy*
chemical_list: D012827:Silicone Oils